| Post Date: | Dec 22,2021 |
| Expiry Date: | Dec 22,2022 |
| Detailed Description: |
Cas No. :52214-84-3
Product name: Ciprofibrate Alias: 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid Molecular formula: C13H14Cl2O3 Molecular weight: 289.16 CAS No.: 52214-84-3 EINECS No.: 257-744-6 Density: 1.37g/cm3 Boiling Point: 424.9°C at 760 mmHg Flash point: 210.7°C From hexane to get light cream solid,Melting point114-116°C. Vapor pressure: 5.63E-08mmHg at 25°C Purity: 98% HPLC Usage: Lipid-lowering drugs, as well as anti-platelet aggregation and the role of soluble fibrin. Little effect in the diet, especially high blood cholesterol or are still in danger of complications, and other drugs alone or in combination treatment of adults with high cholesterol and high endogenous hypertriglyceridemia. |
| CAS Registry Number: | 52214-84-3 |
| Synonyms: | ;2-(p-(2,2-Dichlorocyclopropyl)phenoxy)-2-methylpropionic acid;BRN 1984981;CCRIS 173;Ciprofibrato;Ciprofibrato [INN-Spanish];Ciprofibratum;Ciprofibratum [INN-Latin];UNII-F8252JGO9S;WIN 35833;2-(4-(2,2-Dichlorocyclopropyl)phenoxy)2-methylpropanoic acid;Propanoic acid, 2-(4-(2,2-dichlorocyclopropyl)phenoxy)-2-methyl-; |
| Molecular Formula: | C13H14Cl2O3 |
| Molecular Weight: | 289.1545 |
| Molecular Structure: | 
|
| Hazard Symbols: | |
| Risk Codes: | R45:; |
| Safety Description: | S53:; S22:; S36/37/39:; S45:; |
